Peter G. Schultz

Peter G. Schultz is a renowned American scientist and entrepreneur who has made significant contributions to the field of chemical biology and bioengineering.

Peter G. Schultz is known for his pioneering work in expanding the genetic code of cells, developing new methods for drug discovery, and his contributions to the field of synthetic biology.

The expansion of the genetic code refers to the addition of new building blocks, or unnatural amino acids, to the genetic code of cells. Peter G. Schultz developed methods to incorporate these unnatural amino acids into proteins, enabling the creation of new and diverse proteins with enhanced properties.

Peter G. Schultz has made significant contributions to drug discovery by developing innovative methods for identifying new drug candidates. His work includes the development of high-throughput screening technologies and the creation of large libraries of molecules for drug screening.

Peter G. Schultz co-founded several successful biotechnology companies, including Affymax and Symyx Technologies. These companies have pioneered technologies for drug discovery and materials science, respectively.